JINLING PHARMACEUTICAL COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.15 CNY | -0.14% |
|
-0.97% | -9.15% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.67B 370M | Sales 2023 | 2.79B 386M | Capitalization | 4.02B 557M |
|---|---|---|---|---|---|
| Net income 2022 | 105M 14.54M | Net income 2023 | 99M 13.71M | EV / Sales 2022 | 0.8 x |
| Net cash position 2022 | 1.83B 254M | Net cash position 2023 | 1.51B 209M | EV / Sales 2023 | 0.9 x |
| P/E ratio 2022 |
37.2
x | P/E ratio 2023 |
39.8
x | Employees | 4,871 |
| Yield 2022 |
1.29% | Yield 2023 |
1.27% | Free-Float | 54.06% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.14% | ||
| 1 week | -0.97% | ||
| Current month | +2.73% | ||
| 1 month | +8.83% | ||
| 3 months | +15.51% | ||
| 6 months | -14.47% | ||
| Current year | -9.15% |
1 week
7.08
7.31
1 month
6.337.39
Current year
5.388.24
1 year
5.3810.13
3 years
5.3812.00
5 years
5.3812.00
10 years
5.3830.47
| Managers | Title | Age | Since |
|---|---|---|---|
Sheng Chen
CHM | Chairman | 55 | 17-06-27 |
Guang Yu Yan
BRD | Director/Board Member | 46 | 19-07-31 |
Yang Wang
BRD | Director/Board Member | 46 | 05-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yang Wang
BRD | Director/Board Member | 46 | 05-12-31 |
Yong Jian Shen
BRD | Director/Board Member | 46 | 20-06-21 |
Sheng Chen
CHM | Chairman | 55 | 17-06-27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +3.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 7.15 | -0.14% | 3,830,319 |
| 24-05-16 | 7.16 | -0.28% | 4,113,982 |
| 24-05-15 | 7.18 | -1.24% | 3,868,400 |
| 24-05-14 | 7.27 | +1.82% | 5,230,000 |
| 24-05-13 | 7.14 | -1.11% | 5,741,800 |
End-of-day quote Shenzhen S.E., May 16, 2024
More quotes
Jinling Pharmaceutical Company Limited is a China-based company principally engaged in the manufacture and sale of traditional Chinese medicines and chemical drugs. The Companyâs main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The Company is also involved in the provision of medical services and the sale of medical instrument. The Company distributes its products in domestic market, with North China as its main market.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -9.15% | 623M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- 000919 Stock
